Skip to main navigation Skip to search Skip to main content

Surfactant Administration via Thin Catheter: A Practical Guide

Maximo Vento, Kajsa Bohlin, Egbert Herting, Charles Christoph Roehr, Peter A. Dargaville

Abstract

Exogenous surfactant replacement is the most effective evidence-based therapy for respiratory distress syndrome in preterm infants. The mode of administration has evolved in the last decade towards less invasive techniques that aim to effectively provide an adequate dose of surfactant, while allowing spontaneous respiration to continue, and with the support of continuous positive airway pressure. Surfactant delivery via aerosolisation, pharyngeal instillation, and laryngeal mask are being actively pursued in research, but have not yet been adopted to any significant degree in clinical practice. Surfactant administration via thin catheter, on the other hand, is becoming more widely used in neonatal intensive care units worldwide and is now an acknowledged alternative to the standard mode of surfactant delivery. Different devices, including nasogastric tubes, vascular catheters, and purpose-built surfactant instillation catheters are used. We present here a contemporary review of surfactant administration via thin catheter, in a practical guide format that reflects the individual and collective scientific opinions of the clinicians who participated in formulating the guide.

Original languageEnglish
JournalNeonatology
Volume116
Issue number3
Pages (from-to)211-226
Number of pages16
ISSN1661-7800
DOIs
Publication statusPublished - 01.10.2019

Funding

M.V. and C.C.R. received travel support and financial compensation for invited lectures from Chiesi Farmaceutici. K.B. received travel support and financial compensation for invited lectures from Chiesi Farmaceutici and served as an advisor in the development of the LISAcath. E.H. received grants and travel support from Chiesi Farmaceutici and served as an advisor for Draeger Medical, a company producing incubators, monitors, and ventilators. P.A.D. has undertaken consultancies for Chiesi Farmaceutici, Ab-bvie, and Ikaria, and served as an advisor in the development of the LISAcath.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Surfactant Administration via Thin Catheter: A Practical Guide'. Together they form a unique fingerprint.

Cite this